Anticholinergic burden assessed using general practice electronic records

Journal of Pharmacy Practice and Research

Volumn 43, Issue 3, 2013, Pages 202-205

  Ball, Patrick A ^a   Morrissey, Hana ^b   Pilotto, Louis S J ^c  

^a CHARLES DARWIN UNIVERSITY   (Australia)

^b CHARLES STURT UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; AUSTRALIA; COGNITIVE DEFECT; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PEER REVIEW; PRIMARY MEDICAL CARE; REVIEW; SEX DIFFERENCE;

EID: 84893376147     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2013.tb00255.x     Document Type: Review

References (11)

1. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38: 843-53.
2. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332: 455-8.
3. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000; 93: 457-62.
4. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M. Serum anticholinergic activity in a community-based sample of older adults. Arch Gen Psychiatry 2003; 60: 198-203.
5. Blazer DG, Federspiel CF, Ray WA, Schaffner W. The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol 1983; 38: 31-5.
6. Peters NL. Snipping the thread of life. Antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989; 149: 2414-20.
7. National Drugs and Poisons Schedule Committee. Record of reasons: 51st meeting 16-17 October 2007. Canberra: Therapeutic Goods Administration; 2007.
8. Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 2009; 4: 225-33.
9. Lu CJ, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry 2003; 11: 458-61.
10. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 2011; 59: 1477-83.
11. Therapeutic Goods Act 1989 (CTH) s 7D(1).